Ricardo Eccard da Silva

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Coronavirus Disease

Lymph Node Metastasis

Top Venues

BMC public health

Journal of oncology

Ciencia & saude coletiva

Globalization and health

This page only lists publications with an associated author ORCID identifier.

Publications

Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, Cesar Messias de Oliveira, Dirce Bellezi Guilhem
The impact of social cohesion and risk communication on excess mortality due to COVID-19 in 213 countries: a retrospective analysis. BMC public health 24 (1) (2024)
Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, Cesar Messias de Oliveira, Dirce Bellezi Guilhem
The impact of social cohesion and risk communication on excess mortality due to COVID-19 in 213 countries: a retrospective analysis. BMC public health 24 (1) (2024)
Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, Cesar Messias de Oliveira, Dirce Bellezi Guilhem
The impact of social cohesion and risk communication on excess mortality due to COVID-19 in 213 countries: a retrospective analysis. BMC public health 24 (1) (2024)
Ricardo Eccard da Silva, Maria Rita Carvalho Garbi Novaes, Cesar Messias de Oliveira, Dirce Bellezi Guilhem
National governance and excess mortality due to COVID-19 in 213 countries: a retrospective analysis and perspectives on future pandemics. Globalization and health 19 (1) (2023)
Maria Rita Carvalho Garbi Novaes, Marcia Luz da Motta, Flavia Tavares Silva Elias, Ricardo Eccard da Silva, Cláudia Cardoso Gomes da Silva, Vanessa de Amorim Teixeira Baliero, Marge Tenorio
Incentives and challenges related to technological research and innovation within the Unified Health System in the Federal District of Brazil. Ciencia & saude coletiva 24 (6) (2019)
Ricardo Eccard da Silva, Angélica Amorim Amato, Débora Dornelas Belchior Costa Andrade, Alessandra Vanessa Leite E Silva, Marta Rodrigues de Carvalho, Maria Rita Carvalho Garbi Novaes
Research Priorities and Resource Allocation in the Investigation of New Drugs for Cancer in Least Developed Countries. Journal of oncology 2018 (2018)